These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25976641)

  • 1. OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy.
    Kuehlewein L; Sadda SR; Sarraf D
    Eye (Lond); 2015 Jul; 29(7):932-5. PubMed ID: 25976641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
    Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
    Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
    Altaweel MM; Daniel E; Martin DF; Mittra RA; Grunwald JE; Lai MM; Melamud A; Morse LS; Huang J; Ferris FL; Fine SL; Maguire MG; ;
    Ophthalmology; 2015 Feb; 122(2):391-398.e5. PubMed ID: 25307130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY; Kwon KY; Byeon SH
    Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography angiography during follow-up: qualitative and quantitative analysis of mixed type I and II choroidal neovascularization after vascular endothelial growth factor trap therapy.
    Coscas G; Lupidi M; Coscas F; Français C; Cagini C; Souied EH
    Ophthalmic Res; 2015; 54(2):57-63. PubMed ID: 26201877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy.
    Phasukkijwatana N; Tan ACS; Chen X; Freund KB; Sarraf D
    Br J Ophthalmol; 2017 May; 101(5):597-602. PubMed ID: 27503396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.
    Arnold JJ; Markey CM; Kurstjens NP; Guymer RH
    BMC Ophthalmol; 2016 Mar; 16():31. PubMed ID: 27009515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration.
    Jia Y; Bailey ST; Wilson DJ; Tan O; Klein ML; Flaxel CJ; Potsaid B; Liu JJ; Lu CD; Kraus MF; Fujimoto JG; Huang D
    Ophthalmology; 2014 Jul; 121(7):1435-44. PubMed ID: 24679442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration.
    Nicholson BP; Nigam D; Toy B; Stetson PF; Agrón E; Jacobs-El N; Cunningham D; Cukras C; Wong W; Wiley H; Chew E; Ferris F; Meyerle CB
    Retina; 2015 Jan; 35(1):58-68. PubMed ID: 25077529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Gune S; Abdelfattah NS; Karamat A; Balasubramanian S; Marion KM; Morgenthien E; Sadda SR
    Ophthalmology; 2020 Apr; 127(4):523-532. PubMed ID: 31718842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography angiography-guided photodynamic therapy for extrafoveal choroidal neovascularization.
    Chawla R; Hasan N; Sundar D; Sharma A
    Digit J Ophthalmol; 2020 Jan; 26(1):1-7. PubMed ID: 32547330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and follow-up of type 1 choroidal neovascularisation with optical coherence tomography-angiography after antiangiogenic treatment.
    Torrecillas-Picazo R; Cerdà-Ibáñez M; Almor Palacios I; Hervás Hernandis JM; Ramón-Cosín R; Ruiz Del Rio N; Duch-Samper A
    Arch Soc Esp Oftalmol; 2017 Jun; 92(6):265-272. PubMed ID: 28189273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
    Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
    Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
    [No Abstract]   [Full Text] [Related]  

  • 19. ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD).
    Liakopoulos S; Spital G; Brinkmann CK; Schick T; Ziemssen F; Voegeler J; Koch M; Kirchhof B; Holz FG; Pauleikhoff D; Schmitz-Valckenberg S
    Br J Ophthalmol; 2020 Nov; 104(11):1573-1578. PubMed ID: 32066561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration.
    Iacono P; Parodi MB; Introini U; La Spina C; Varano M; Bandello F
    Retina; 2014 Feb; 34(2):281-7. PubMed ID: 23851632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.